Table 1.
Molecular target | Genetic aberration (%) | Type aberration |
---|---|---|
EGFR | 43%–69% | overexpression |
VEGF | 93% | overexpression |
KRAS | 90% | point mutation |
BRAF | 30% | point mutation |
AKT2 | 15% | amplification |
MYB | 10% | amplification |
IGF-1R | 64% | amplification |
MMPs | 85% | amplification |
Hedgeogh | 70% | amplification |
m-TOR | 65% | overexpression |
MEK | 72% | point mutation |
COX-2 | 67%–90% | point mutation |